111 related articles for article (PubMed ID: 14605857)
1. Modelling the early growth of ductal carcinoma in situ of the breast.
Franks SJ; Byrne HM; King JR; Underwood JC; Lewis CE
J Math Biol; 2003 Nov; 47(5):424-52. PubMed ID: 14605857
[TBL] [Abstract][Full Text] [Related]
2. Mathematical modelling of comedo ductal carcinoma in situ of the breast.
Franks SJ; Byrne HM; Mudhar HS; Underwood JC; Lewis CE
Math Med Biol; 2003 Sep; 20(3):277-308. PubMed ID: 14667048
[TBL] [Abstract][Full Text] [Related]
3. Biological inferences from a mathematical model of comedo ductal carcinoma in situ of the breast.
Franks SJ; Byrne HM; Underwood JC; Lewis CE
J Theor Biol; 2005 Feb; 232(4):523-43. PubMed ID: 15588633
[TBL] [Abstract][Full Text] [Related]
4. A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression.
Norton KA; Wininger M; Bhanot G; Ganesan S; Barnard N; Shinbrot T
J Theor Biol; 2010 Apr; 263(4):393-406. PubMed ID: 20006623
[TBL] [Abstract][Full Text] [Related]
5. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
[TBL] [Abstract][Full Text] [Related]
6. [Clinicopathologic study of breast cancer with features of endocrine ductal carcinoma-in-situ].
Yang WT; Xu YX; Zhang TQ
Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):594-7. PubMed ID: 17134566
[TBL] [Abstract][Full Text] [Related]
7. Computational model of ductal carcinoma in situ: the effects of contact inhibition on pattern formation.
Shumate SD; El-Shenawee M
IEEE Trans Biomed Eng; 2009 May; 56(5):1341-7. PubMed ID: 19272932
[TBL] [Abstract][Full Text] [Related]
8. The molecular journey from ductal carcinoma in situ to invasive breast cancer.
Wiechmann L; Kuerer HM
Cancer; 2008 May; 112(10):2130-42. PubMed ID: 18383519
[TBL] [Abstract][Full Text] [Related]
9. Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.
Osuala KO; Sameni M; Shah S; Aggarwal N; Simonait ML; Franco OE; Hong Y; Hayward SW; Behbod F; Mattingly RR; Sloane BF
BMC Cancer; 2015 Aug; 15():584. PubMed ID: 26268945
[TBL] [Abstract][Full Text] [Related]
10. Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.
Daoud SA; Ismail WM; Abdelhamid MS; Nabil TM; Daoud SA
Asian Pac J Cancer Prev; 2016; 17(8):3733-6. PubMed ID: 27644608
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.
Vestey SB; Perks CM; Sen C; Calder CJ; Holly JM; Winters ZE
Breast Cancer Res; 2005; 7(1):R119-29. PubMed ID: 15642160
[TBL] [Abstract][Full Text] [Related]
12. HER2 status in pure ductal carcinoma in situ and in the intraductal and invasive components of invasive ductal carcinoma determined by fluorescence in situ hybridization and immunohistochemistry.
Park K; Han S; Kim HJ; Kim J; Shin E
Histopathology; 2006 May; 48(6):702-7. PubMed ID: 16681686
[TBL] [Abstract][Full Text] [Related]
13. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
14. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
15. A simple model of breast carcinoma growth may provide explanations for observations of apparently complex phenomena.
Kopans DB; Rafferty E; Georgian-Smith D; Yeh E; D'Alessandro H; Moore R; Hughes K; Halpern E
Cancer; 2003 Jun; 97(12):2951-9. PubMed ID: 12784329
[TBL] [Abstract][Full Text] [Related]
16. Identification of biomarkers in ductal carcinoma in situ of the breast with microinvasion.
Okumura Y; Yamamoto Y; Zhang Z; Toyama T; Kawasoe T; Ibusuki M; Honda Y; Iyama K; Yamashita H; Iwase H
BMC Cancer; 2008 Oct; 8():287. PubMed ID: 18837981
[TBL] [Abstract][Full Text] [Related]
17. Ductal carcinoma in situ (DCIS) of the breast--a therapeutic dilemma.
van Dongen JA; Bartelink H; Fentiman IS; Peterse JL
Eur J Surg Oncol; 1987 Apr; 13(2):123-5. PubMed ID: 3030824
[TBL] [Abstract][Full Text] [Related]
18. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
Ottesen GL
APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
[TBL] [Abstract][Full Text] [Related]
19. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
20. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]